U.S. Orthopedic Biomaterials Market Growing to Exceed $7B by 2030, Driven by Aging Population and Obesity Rates

VANCOUVER, BC, CANADA, June 3, 2024 /EINPresswire.com/ -- iData Research, a leading international market research firm, proudly announces the release of its detailed report on the U.S. Orthopedic Biomaterials market. These reports offer not only market data and forecasts but also analyze key competitors within each region. The full report suite on the U.S. market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrices (DBMs), xenografts and synthetic bone graft markets. The report also includes orthopedic growth factors; cellular allografts; orthopedic cell therapy, represented by bone marrow aspirate concentrate and platelet-rich plasma; hyaluronic acid (HA) viscosupplementation in single-, two-, three- and five-injection cycles; and, finally, orthopedic cartilage repair. Cartilage repair is represented by the osteochondral allograft, meniscal allograft, autologous chondrocyte implantation, particulated juvenile allograft and microfracture adjunct segments.

The elderly demographic significantly drives the market for orthopedic therapies. As this population segment grows, so does the incidence of osteoarthritis and other degenerative diseases, leading to increased demand for orthopedic biomaterials. Additionally, the high obesity rates in the U.S. contribute to the rise in degenerative diseases, further boosting the need for these products. A notable portion of the biomaterials market addresses soft-tissue injuries, predominantly from sports. Specifically, the platelet-rich plasma market has shifted from orthopedic to sports medicine applications. This area is gaining interest in biologic and regenerative therapies, as sports medicine patients prioritize maintaining high activity levels.

Key highlights from iData's report include:

Robust Market Expansion: In 2023, the U.S. orthopedic biomaterials market reached a value exceeding $5.0 billion. Projections indicate a healthy growth trajectory, with the market anticipated to approach $7.2 billion by the end of the forecast period.

Potential Market Limiter: Contamination risk poses a significant challenge in the orthopedic biomaterials market. In 2021, the CDC linked a tuberculosis outbreak among 100 spinal surgery patients to contaminated graft material from a single donor, resulting in eight deaths. A similar TB outbreak occurred in 2023, affecting 36 patients and causing one death. These incidents have heightened concerns about donor screening and tissue processing, leading many surgeons to opt for safer alternatives. This shift negatively impacts the bone graft substitute market and may also limit the growth potential of the cellular allograft market.

Competitive Landscape: In 2023, Medtronic, DePuy Synthes, and Stryker were the frontrunners in the U.S. orthopedic biomaterials market, securing the largest shares. The report also analyzes other major players, including Allergan, Arthrex, Bioventus, CONMED, Globus Medical, NuVasive, Orthofix, Smith & Nephew, Terumo, and Zimmer Biomet, to name a few.

For more details or to purchase the report, please visit the following link.

https://idataresearch.com/product/orthopedic-biomaterials-market-united-states/

About iData

iData Research stands out as the premier market research and intelligence provider, offering unparalleled insights and comprehensive data analysis across a multitude of industries. With a strong reputation and a proven track record, iData Research has solidified its position as the best choice for businesses seeking to make informed decisions in today's dynamic market landscape.

Why Should You Choose iData?

Extensive Industry Coverage: iData Research boasts an impressive range of industry coverage, spanning healthcare, medical devices, dental, pharmaceuticals, biotechnology, and more. This breadth of coverage ensures that clients from various sectors can access accurate, up-to-date information relevant to their business goals.

High-Quality Data: The cornerstone of iData Research's success is its commitment to providing high-quality data. Their team of expert analysts employs rigorous methodologies to collect and analyze data from reliable sources. This ensures that clients receive accurate, insightful, and actionable information to guide their strategic decisions.

In-Depth Analysis: iData Research goes beyond mere data presentation by offering in-depth analysis that goes right to the heart of industry trends, market dynamics, and competitive landscapes. Their reports provide a holistic understanding of market forces, helping clients identify opportunities and challenges.

Customized Solutions: Recognizing that every business is unique, iData Research offers customizable solutions that cater to specific client needs. Whether it's a small startup or a multinational corporation, their tailored offerings provide the right insights to drive growth and success.

Timely Updates: Staying ahead in today's fast-paced business environment requires access to real-time information. iData Research ensures that its clients are equipped with the latest data and insights, enabling them to make agile decisions and adapt to market changes swiftly.

Global Perspective: In an increasingly interconnected world, having a global perspective is essential. iData Research's reports provide insights into various geographic markets, enabling clients to make informed decisions regardless of their business's location.

Trusted by Industry Leaders: The fact that iData Research is trusted by industry leaders and renowned companies speaks volumes about the quality of their services. Their client list includes major players who rely on their insights for strategic planning.

Emma Matrick
iData Research
7785493830 ext.
email us here
Visit us on social media:
Facebook
X
LinkedIn